ANZBMS 2026 , ,
Presentations this author is a contributor to:
Repurposing FDA-Approved Drugs Targeting OXR1 to Suppress Osteoclastogenesis and Prevent Bone Loss (#6)
11:00 AM
Xiaojun X.C. Chen
Roger Melick Young Investigator Award Symposium